RxDoctor Payments Data

Mahindranauth Deonarine, MD

Psychiatry · Lanham, MDNPI 1841253127

Payments from drug & device makers

$1,741in general payments, 2019–2025

Across 115 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$420
  • Otsuka America Pharmaceutical, Inc.$356
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$246
  • Vanda Pharmaceuticals Inc.$212
  • Supernus Pharmaceuticals, Inc.$116
  • Alkermes, Inc.$93
  • plus $298 from 7 others

What the payments were for

  • Food & beverage$1,69197%
  • Education$503%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,741 in reported general payments places this provider in the 80th percentile of 851 psychiatry providers in Maryland.

See all psychiatry providers in Maryland

Medicare billing

Part B allowed, 2024
$103,916
Medicare patients
94
Services billed
659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl45$68,633
Abilify MaintenaAripiprazole26$62,949
AuvelityDextromethorphan Hbr/Bupropion14$26,773
RexultiBrexpiprazole13$18,107
TrintellixVortioxetine Hydrobromide12$15,237
Aripiprazole69$4,018
CymbaltaDuloxetine Hcl13$3,460
Focalin XrDexmethylphenidate Hcl12$2,553
Bupropion XlBupropion Hcl111$2,202
Olanzapine62$1,921
Lisdexamfetamine Dimesylate11$1,902
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine56$1,837
Fluphenazine Hcl16$1,529
Haloperidol44$1,418
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$1,079

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$356$81,05639 claims
AbbVieVraylar$420$68,63345 claims
Axsome Therapeutics, Inc.Auvelity$67$26,77314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 851 psychiatry providers in Maryland.

Other psychiatry in Lanham

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →